NCT01818570View on ClinicalTrials.gov

A Study of Local Effect and Safety of a Single PPC-5650 Dose on Reflux Pain During Pain Stimulation in the Esophagus

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Gastroesophageal RefluxGastroesophageal Reflux Disease
Interventions
DRUG

PPC-5650

A dose of 2.5 mg PPC-5650 in a 100 ml solution will be administered to the esophagus with an infusion rate of 7ml/min in one out of three visit days.

DRUG

Placebo

A 100 ml placebo solution will be administered to the esophagus with an infusion rate of 7ml/min in one out of three visit days.

Trial Locations (1)

9000

Mech-Sense, Department of Medical Gastroenterology, Aalborg University Hospital, Aalborg

All Listed Sponsors
lead

Asbjørn Mohr Drewes

OTHER

NCT01818570 - A Study of Local Effect and Safety of a Single PPC-5650 Dose on Reflux Pain During Pain Stimulation in the Esophagus | Biotech Hunter | Biotech Hunter